Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

被引：2
作者：
Coombes, Ian D. [1 ,2 ,3 ]
Legg, Amy [1 ,3 ,4 ,6 ]
Patterson, Tina [3 ,5 ,6 ]
Kelly, Tanya [3 ,7 ,8 ]
Henderson, Andrew [3 ,5 ,9 ]
Roberts, Jason A. [1 ,3 ,4 ,10 ,11 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
[2] Univ Queensland, Dept Pharm, Brisbane, Qld, Australia
[3] COVID 19 Med Pharm Planning & Response Grp, Brisbane, Qld, Australia
[4] Metro North Hlth, Herston Infect Dis Inst HeIDI, Brisbane, Qld, Australia
[5] COVID 19 Clin Therapeut Guideline Working Grp, Brisbane, Qld, Australia
[6] Logan Hosp, Dept Pharm, Brisbane, Qld, Australia
[7] Sunshine Coast Univ Hosp, Dept Anaesthesia & Perioperat Med, Sunshine Coast, Qld, Australia
[8] Queensland Clin Senate, Clin Excellence Queensland, Brisbane, Qld, Australia
[9] Princess Alexandra Hosp, Dept Infect Dis, Brisbane, Qld, Australia
[10] Univ Queensland, Fac Med, Ctr Clin Res, Brisbane, Qld, Australia
[11] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
来源：
AUSTRALIAN PRESCRIBER | 2022年 / 45卷 / 02期
关键词：
COVID-19; molnupiravir; nirmatrelvir/ritonavir; quality use of medicines; SARS-CoV-2;
D O I：
10.18773/austprescr.2022.021
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
[41]   Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency [J].
Lesichkova, Spaska ;
Mihailova, Snezhina ;
Naumova, Elisaveta ;
Yankova, Petya ;
Krasteva, Yana ;
Marinova, Ralitsa .
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 47 (04) :357-361
[42]   Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19 [J].
Kim, Taeyun ;
Joo, Dong-Hyun ;
Lee, Seung Woo ;
Lee, Jaejun ;
Lee, Sang Jin ;
Kang, Jihun .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
[43]   Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study [J].
Jang, Young Rock ;
Oh, Yoon Ju ;
Kim, Jin Yong .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
[44]   CLINICAL AND LABORATORY CHARACTERISTICS OF MILD/MODERATE COVID-19 IN PREGNANT WOMEN, BASED ON THE DURATION OF GESTATION [J].
Suleimanova, Naida Dairovna ;
Rahimov, Razin Mirzekerimovich ;
Abdullaeva, Naida Murtazalievna ;
Alieva, Sabina Rosenovna ;
Muslimova, Asli Eminovna .
PHARMACOPHORE, 2021, 12 (03) :18-22
[45]   Antivirals in COVID-19: A Focus on Pediatric Cardiac Patients [J].
Safi, Dalia ;
Khouri, Farah ;
Zareef, Rana ;
Arabi, Mariam .
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2025, 2025 (01)
[46]   Antimalarials as Antivirals for COVID-19: Believe it or Not! [J].
Saha, Biplab K. ;
Bonnier, Alyssa ;
Chong, Woon .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2020, 360 (06) :618-630
[47]   Antivirals for COVID-19: A critical review [J].
Frediansyah, Andri ;
Tiwari, Ruchi ;
Sharun, Khan ;
Dhama, Kuldeep ;
Harapan, Harapan .
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 9 :90-98
[48]   Efficacy of Molnupiravir for the Treatment of Mild or Moderate COVID-19 in Adults: A Meta-Analysis [J].
Benaicha, Karima ;
Khenhrani, Raja Ram ;
Veer, Maha ;
Devi, Sapna ;
Shahbaz, Usman ;
Salah, Qais M. ;
Hammad, Mostafa ;
Palleti, Sujith K. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
[49]   Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients [J].
Haddad, Andrea J. ;
Hachem, Ray Y. ;
Moussa, Mohamed ;
Jiang, Ying ;
Dagher, Hiba R. ;
Chaftari, Patrick ;
Chaftari, Anne-Marie ;
Raad, Issam I. .
CANCERS, 2024, 16 (05)
[50]   Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review [J].
Jomah, Shahamah ;
Asdaq, Syed Mohammed Basheeruddin ;
Al-Yamani, Mohammed Jaber .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (09) :1187-1195
12345